Candriam Equities L Oncology Impact R2 Fonds
147,38
USD
+1,37
USD
+0,94
%
NAV
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Merck & Co Inc | US58933Y1055 | 6,81% |
| Roche Holding AG | CH0012032048 | 6,41% |
| AstraZeneca PLC | GB0009895292 | 6,27% |
| Eli Lilly and Co | US5324571083 | 6,25% |
| Novartis AG Registered Shares | CH0012005267 | 6,22% |
| Siemens Healthineers AG Registered Shares | DE000SHL1006 | 5,48% |
| Hologic Inc | US4364401012 | 4,81% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 4,34% |
| Thermo Fisher Scientific Inc | US8835561023 | 4,18% |
| Gilead Sciences Inc | US3755581036 | 3,41% |
| Sonstige | 45,81% |